Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000919574-25-001515·Casdin Capital, LLC
Schedule 13G ownership disclosure
Neurogene Inc
Common Stock, $0.000001 par value · CUSIP: 64135M105
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Casdin Capital, LLC
Shares: 1,295,361.00 · Class: 8.7%
- Casdin Partners Master Fund, L.P.
Shares: 1,075,000.00 · Class: 7.2%
- Casdin Partners GP, LLC
Shares: 1,075,000.00 · Class: 7.2%
- Eli Casdin
Shares: 1,295,361.00 · Class: 8.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-25-001515
- Form type
- SCHEDULE 13G/A
- Filer
- Casdin Capital, LLC
- CIK
- CIK 1534261
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership